Covid-19 A New Viral Trigger to Hemophagocytic Lymphohistiocytosis?
1. Summary
We report a case of patient with COVID-19 pneumonia who had prolong course in critical care unit and developed clinical and laboratory features of Hemophagocytic Lymphohistiocystosis (HLH) supported by findings on bone marrow. Patient received supportive treatment and IL-6 inhibitor but developed multiorgan failure and could not revive back to life. HLH is life threatening condition with rapid course and can lead to multiorgan failure and death. This case highlights the importance of fact that HLH can lead to significant morbidity and mortality in critically ill patient with COVID-19 pneumonia and it warrants early evaluation in these patients.